Ren Zhang
Guangzhou, 510006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Cycloechinulin inhibits breast cancer progression via the SGOL2/METTL3/ICAM2 signaling axis and suppresses the growth of breast cancer patient-derived organoids.
Journal: Cellular signalling
Published: June 08, 2026
TIMM9 as a prognostic biomarker in multiple cancers and its associated biological processes.
Journal: Scientific reports
Published: April 11, 2024
Berberine synergises with ferroptosis inducer sensitizing NSCLC to ferroptosis in p53-dependent SLC7A11-GPX4 pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 12, 2024
miR-122-3p targets UBE2I to regulate the immunosuppression of liver cancer and the intervention of Liujunzi formula.
Journal: Journal of ethnopharmacology
Published: January 28, 2024
Inhibitory Effects and Mechanism of the Natural Compound Diaporthein B Extracted from Marine-Derived Fungi on Colon Cancer Cells.
Journal: Molecules (Basel, Switzerland)
Published: March 30, 2022
Study on the mechanism of Cortex Lycii on lung cancer based on network pharmacology combined with experimental validation.
Journal: Journal of ethnopharmacology
Published: December 07, 2021
Absorption characteristics of ilexgenin A and ilexsaponin B1 in human umbilical vein endothelial cells after administration of the total triterpenoid saponins from Ilex pubescens.
Journal: Biomedical chromatography : BMC
Published: November 29, 2021
N6-methyladenosine modification of TGM2 mRNA contributes to the inhibitory activity of sarsasapogenin in rheumatoid arthritis fibroblast-like synoviocytes.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 27, 2021
Demethyleneberberine induces cell cycle arrest and cellular senescence of NSCLC cells via c-Myc/HIF-1α pathway.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: April 26, 2021
Network Pharmacology and Experimental Evidence Reveal Dioscin Suppresses Proliferation, Invasion, and EMT via AKT/GSK3b/mTOR Signaling in Lung Adenocarcinoma.
Journal: Drug design, development and therapy
Published: June 18, 2020
Last Updated: 09/26/2026